Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	23.43B
Revenue (ttm)	1.98B
Net Income (ttm)	387.42M
Shares Out	733.37M
EPS (ttm)	0.51
PE Ratio	65.33
Forward PE	69.05
Dividend	0.03 (0.08%)
Ex-Dividend Date	Jul 31, 2024

Volume	57,850,916
Average Volume	38,686,617
Open	34.10
Previous Close	35.18
Day's Range	32.34 - 37.00
52-Week Range	13.02 - 35.20
Beta	0.72
RSI	75.74
Earnings Date	Aug 27, 2025

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.